🦠 Hundreds of thousands of children with sickle cell disease are currently deprived of care, particularly in Sub-Saharan Africa and about 50% of them die within 5 years. Hydroxyurea (HU), which has been known to be effective in sickle cell disease for 20 years, is highly effective in preventing vaso-occlusive crises and has been on the WHO's list of essential medicines since 2013 Doctors Without Borders develops access to SCD services, such as diagnosis, treatment, and follow-up in primary heal